Skip to main content
Clinical Trials/CTRI/2023/04/051532
CTRI/2023/04/051532
Not yet recruiting
Phase 3

An upshayatmak clinical comparative study on Hyperlipidemia (Medo Roga) with Trikatu Churna and Medohar Gugglu W.S.R to lipid profile.

S.A.M.C.H INDORE0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
S.A.M.C.H INDORE
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
S.A.M.C.H INDORE

Eligibility Criteria

Inclusion Criteria

  • 1\- Patient presenting with clinical features of Hyperlipidemia ( Medo Roga)
  • 2\- Both new and old patients of High Blood lipid Profile are included in the study
  • 3\- Normal level of serum cholesterol, Tryglyceride, LDL\-C, HDL\-C , refrence range has been chosen according to Indian heart association.
  • 4\- Patients willing to participate in the study and after giving their consent.

Exclusion Criteria

  • 1\- Patients not fulfilling the inclusion criteria.
  • 2\- Drug induced or uncontrolled hyperlipidemia.
  • 3\- Patients suffering from type 1 Diabetes and uncontrolled Diabetes mellitus or uncontrolled Hypertension.
  • 4\- Patients having systematic illness like tuberculosis, carcinoma and endocrine disorders or major illness like renal or liver disorders etc

Outcomes

Primary Outcomes

Not specified

Similar Trials